Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

State-of-the-Art

Anticoagulant and antithrombotic drugs in pregnancy: what are the anesthetic implications for labor and cesarean delivery?

Journal of Perinatology volume 31, pages 73–84 (2011)Cite this article

Subjects

Abstract

Neuraxial anesthetic techniques are commonly used during the peripartum period to provide effective pain relief for labor and anesthesia during cesarean delivery. Major neurologic complications are rare after neuraxial anesthesia; however, spinal hematoma is associated with catastrophic neurologic outcomes (including lower-limb paralysis). Anticoagulant and antithrombotic drugs can increase the risk of spinal hematoma after neuraxial anesthesia, and better understanding of the pharmacokinetics and pharmacodynamics of anticoagulants has led to greater appreciation for withholding anticoagulation before and after neuraxial anesthesia. A number of national anesthetic societies have produced guidelines for performing neuraxial anesthesia in patients receiving anticoagulation. However, there is limited information about anesthetic implications of anticoagulation during the peripartum period. This article will review the risks of spinal hematoma after neuraxial anesthesia in pregnant patients; current guidelines for neuraxial anesthesia for anticoagulated patients; and relevant pharmacological data of specific anticoagulant and antithrombotic drugs in pregnancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  1. ACOG practice bulletin. Obstetric analgesia and anesthesia.number 36, July 2002 American college of obstetrics and gynecology. Int J Gynaecol Obstet 2002; 78: 321–335.

    Article  Google Scholar 

  2. Cohen SE, Subak LL, Brose WG, Halpern J . Analgesia after cesarean delivery: patient evaluations and costs of five opioid techniques. Reg Anesth 1991; 16: 141–149.

    CAS  PubMed  Google Scholar 

  3. Harrison DM, Sinatra R, Morgese L, Chung JH . Epidural narcotic and patient-controlled analgesia for post-cesarean section pain relief. Anesthesiology 1988; 68: 454–457.

    Article  CAS  PubMed  Google Scholar 

  4. Bloom SL, Spong CY, Weiner SJ, Landon MB, Rouse DJ, Varner MW et al. Complications of anesthesia for cesarean delivery. Obstet Gynecol 2005; 106: 281–287.

    Article  PubMed  Google Scholar 

  5. Hawkins JL, Koonin LM, Palmer SK, Gibbs CP . Anesthesia-related deaths during obstetric delivery in the United States, 1979–1990. Anesthesiology 1997; 86: 277–284.

    Article  CAS  PubMed  Google Scholar 

  6. Bucklin BA, Hawkins JL, Anderson JR, Ullrich FA . Obstetric anesthesia workforce survey: twenty-year update. Anesthesiology 2005; 103: 645–653.

    Article  PubMed  Google Scholar 

  7. Groen RJ, van Alphen HA . Operative treatment of spontaneous spinal epidural hematomas: a study of the factors determining postoperative outcome. Neurosurgery 1996; 39: 494–508, discussion 508–509.

    CAS  PubMed  Google Scholar 

  8. Lawton MT, Porter RW, Heiserman JE, Jacobowitz R, Sonntag VK, Dickman CA . Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome. J Neurosurg 1995; 83: 1–7.

    Article  CAS  PubMed  Google Scholar 

  9. Kreppel D, Antoniadis G, Seeling W . Spinal hematoma: a literature survey with meta-analysis of 613 patients. Neurosurg Rev 2003; 26: 1–49.

    Article  CAS  PubMed  Google Scholar 

  10. Forsnes E, Occhino A, Acosta R . Spontaneous spinal epidural hematoma in pregnancy associated with using low molecular weight heparin. Obstet Gynecol 2009; 113: 532–533.

    Article  PubMed  Google Scholar 

  11. Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost 2008; 34: 58–73.

    Article  CAS  PubMed  Google Scholar 

  12. Roofthooft E . Anesthesia for the morbidly obese parturient. Curr Opin Anaesthesiol 2009; 22: 341–346.

    Article  PubMed  Google Scholar 

  13. Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 2007; 197: 457 e451–421.

    Article  PubMed  CAS  Google Scholar 

  14. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J . Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 844S–886S.

    Article  CAS  PubMed  Google Scholar 

  15. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (Third Edition). Reg Anesth Pain Med 2010; 35: 64–101.

    Article  CAS  PubMed  Google Scholar 

  16. Clinical guidelines for inhibitors of hemostasis locoregional neuraxial anesthesia spanish society of anesthesiology-resuscitation and pain therapy, division of hemostasis, transfusion medicine, and perioperative fluid therapy. Rev Esp Anestesiol Reanim 2005; 52: 413–420.

  17. Gogarten W, Van Aken H, Büttner J, Riess H, Wulf H, Bürkle H . Regional anaesthesia and thromboembolism prophylaxis/anticoagulation—revised recommendations of the German society of anaesthesiology and intensive care medicine. Anaesthesiol Intensivmed 2007; 48: S109–S124.

    Google Scholar 

  18. Kozek-Langenecker SA, Fries D, Gutl M, Hofmann N, Innerhofer P, Kneifl W et al. Locoregional anesthesia and coagulation inhibitors. recommendations of the task force on perioperative coagulation of the Austrian society for anesthesiology and intensive care medicine. Anaesthesist 2005; 54: 476–484.

    Article  CAS  PubMed  Google Scholar 

  19. Nederlandse Vereniging voor Anesthesiologie. Guidelines on neuraxial blockade and antithrombotic therapy. 2003.

  20. Societe Francaise d'anesthesie et de reanimation Les blocs perimedullaires chez l'adulte. Recommandations pour la pratique clinique 2006.

  21. Vandermeulen E, Singelyn F, Vercauteren M, Brichant JF, Ickx BE, Gautier P . Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. Acta Anaesthesiol Belg 2005; 56: 139–146.

    CAS  PubMed  Google Scholar 

  22. Vandermeulen EP, Van Aken H, Vermylen J . Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79: 1165–1177.

    Article  CAS  PubMed  Google Scholar 

  23. Horlocker TT, Wedel DJ . Spinal and epidural blockade and perioperative low molecular weight heparin: smooth sailing on the Titanic. Anesth Analg 1998; 86: 1153–1156.

    CAS  PubMed  Google Scholar 

  24. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172–197.

    PubMed  Google Scholar 

  25. Wysowski DK, Talarico L, Bacsanyi J, Botstein P . Spinal and epidural hematoma and low-molecular-weight heparin. N Engl J Med 1998; 338: 1774–1775.

    Article  CAS  PubMed  Google Scholar 

  26. Moen V, Dahlgren N, Irestedt L . Severe neurological complications after central neuraxial blockades in Sweden 1990–1999. Anesthesiology 2004; 101: 950–959.

    Article  CAS  PubMed  Google Scholar 

  27. Ruppen W, Derry S, McQuay H, Moore RA . Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/anesthesia. Anesthesiology 2006; 105: 394–399.

    Article  PubMed  Google Scholar 

  28. Cook TM, Counsell D, Wildsmith JA . Major complications of central neuraxial block: report on the third national audit project of the royal college of anaesthetists. Br J Anaesth 2009; 102: 179–190.

    Article  CAS  PubMed  Google Scholar 

  29. Davies JM, Posner KL, Lee LA, Cheney FW, Domino KB . Liability associated with obstetric anesthesia: a closed claims analysis. Anesthesiology 2009; 110: 131–139.

    Article  PubMed  Google Scholar 

  30. Greer IA, Nelson-Piercy C . Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 2005; 106: 401–407.

    Article  CAS  PubMed  Google Scholar 

  31. Maslovitz S, Many A, Landsberg JA, Varon D, Lessing JB, Kupferminc MJ . The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonatal Med 2005; 17: 39–43.

    Article  CAS  PubMed  Google Scholar 

  32. Nelson-Piercy C, Letsky EA, de Swiet M . Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176: 1062–1068.

    Article  CAS  PubMed  Google Scholar 

  33. Kominiarek MA, Angelopoulos SM, Shapiro NL, Studee L, Nutescu EA, Hibbard JU . Low-molecular-weight heparin in pregnancy: peripartum bleeding complications. J Perinatol 2007; 27: 329–334.

    Article  CAS  PubMed  Google Scholar 

  34. Lambert JR, Austin SK, Peebles D, Cohen H . Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin. Br J Haematol 2008; 142: 453–456.

    Article  CAS  PubMed  Google Scholar 

  35. Cleary-Goldman J, Bettes B, Robinson JN, Norwitz E, Schulkin J . Thrombophilia and the obstetric patient. Obstet Gynecol 2007; 110: 669–674.

    Article  PubMed  Google Scholar 

  36. Krombach JW, Dagtekin O, Kampe S . Regional anesthesia and anticoagulation. Curr Opin Anaesthesiol 2004; 17: 427–433.

    Article  PubMed  Google Scholar 

  37. Llau JV, De Andres J, Gomar C, Gomez-Luque A, Hidalgo F, Torres LM . Anticlotting drugs and regional anaesthetic and analgesic techniques: comparative update of the safety recommendations. Eur J Anaesthesiol 2007; 24: 387–398.

    Article  CAS  PubMed  Google Scholar 

  38. Akkad A, Oppenheimer C, Mushambi M, Pavord S . Intrapartum care for women on full anticoagulation. Int J Obstet Anesth 2003; 12: 188–192.

    Article  CAS  PubMed  Google Scholar 

  39. Kandrotas RJ . Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992; 22: 359–374.

    Article  CAS  PubMed  Google Scholar 

  40. Brancazio LR, Roperti KA, Stierer R, Laifer SA . Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 1995; 173: 1240–1245.

    Article  CAS  PubMed  Google Scholar 

  41. Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P et al. The APTT response of pregnant plasma to unfractionated heparin. Thromb Haemost 2002; 87: 92–97.

    Article  CAS  PubMed  Google Scholar 

  42. Greer I, Hunt BJ . Low molecular weight heparin in pregnancy: current issues. Br J Haematol 2005; 128: 593–601.

    Article  CAS  PubMed  Google Scholar 

  43. Hemker HC, Beguin S . Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma. Haemostasis 1990; 20 (Suppl 1): 81–92.

    CAS  PubMed  Google Scholar 

  44. Gerotziafas GT, Bara L, Bloch MF, Makris PE, Samama MM . Comparative effects of synthetic pentasaccharide, low-molecular-weight heparin, unfractionated heparin and recombinant hirudin on the generation of factor VIIa and prothrombin activation after coagulation of human plasma. Blood Coagul Fibrinolysis 1998; 9: 571–580.

    Article  CAS  PubMed  Google Scholar 

  45. Bara L, Bloch MF, Zitoun D, Samama M, Collignon F, Frydman A et al. Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor. Thromb Res 1993; 69: 443–452.

    Article  CAS  PubMed  Google Scholar 

  46. Samama MM, Gerotziafas GT . Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 2000; 26 (Suppl 1): 31–38.

    Article  CAS  PubMed  Google Scholar 

  47. Norris LA, Bonnar J, Smith MP, Steer PJ, Savidge G . Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study. Thromb Haemost 2004; 92: 791–796.

    Article  CAS  PubMed  Google Scholar 

  48. Sephton V, Farquharson RG, Topping J, Quenby SM, Cowan C, Back DJ et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003; 101: 1307–1311.

    CAS  PubMed  Google Scholar 

  49. Blomback M, Bremme K, Hellgren M, Lindberg H . A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy. Blood Coagul Fibrinolysis 1998; 9: 343–350.

    Article  CAS  PubMed  Google Scholar 

  50. Casele HL, Laifer SA, Woelkers DA, Venkataramanan R . Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol 1999; 181: 1113–1117.

    Article  CAS  PubMed  Google Scholar 

  51. Lebaudy C, Hulot JS, Amoura Z, Costedoat-Chalumeau N, Serreau R, Ankri A et al. Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy. Clin Pharmacol Ther 2008; 84: 370–377.

    Article  CAS  PubMed  Google Scholar 

  52. Frydman AM, Bara L, Le Roux Y, Woler M, Chauliac F, Samama MM . The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20–80 mg. J Clin Pharmacol 1988; 28: 609–618.

    Article  CAS  PubMed  Google Scholar 

  53. Eriksson BI, Soderberg K, Widlund L, Wandeli B, Tengborn L, Risberg B . A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers. Thromb Haemost 1995; 73: 398–401.

    CAS  PubMed  Google Scholar 

  54. Hammerstingl C, Omran H, Tripp C, Poetzsch B . How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study. Thromb Haemost 2009; 101: 325–332.

    Article  CAS  PubMed  Google Scholar 

  55. Greaves M . Limitations of the laboratory monitoring of heparin therapy. Scientific and standardization committee communications: on behalf of the control of anticoagulation subcommittee of the scientific and standardization committee of the international society of thrombosis and haemostasis. Thromb Haemost 2002; 87: 163–164.

    Article  CAS  PubMed  Google Scholar 

  56. Ellison J, Thomson AJ, Conkie JA, McCall F, Walker D, Greer A . Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin. Thromb Haemost 2001; 86: 1374–1378.

    Article  CAS  PubMed  Google Scholar 

  57. Samama MM, Gerotziafas GT . Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). Thromb Res 2003; 109: 1–11.

    Article  CAS  PubMed  Google Scholar 

  58. Boneu B, Necciari J, Cariou R, Sie P, Gabaig AM, Kieffer G et al. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man. Thromb Haemost 1995; 74: 1468–1473.

    Article  CAS  PubMed  Google Scholar 

  59. Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE . Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost 2007; 97: 496–497.

    Article  CAS  PubMed  Google Scholar 

  60. Mazzolai L, Hohlfeld P, Spertini F, Hayoz D, Schapira M, Duchosal MA . Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood 2006; 108: 1569–1570.

    Article  CAS  PubMed  Google Scholar 

  61. Lagrange F, Vergnes C, Brun JL, Paolucci F, Nadal T, Leng JJ et al. Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro. Thromb Haemost 2002; 87: 831–835.

    Article  CAS  PubMed  Google Scholar 

  62. Dempfle CE . Minor transplacental passage of fondaparinux in vivo. N Engl J Med 2004; 350: 1914–1915.

    Article  CAS  PubMed  Google Scholar 

  63. Roth GJ, Majerus PW . The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest 1975; 56: 624–632.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Roth GJ, Stanford N, Majerus PW . Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073–3076.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Rymark P, Berntorp E, Nordsjo P, Liedholm H, Melander A, Gennser G . Low-dose aspirin to pregnant women: single dose pharmacokinetics and influence of short term treatment on bleeding time. J Perinat Med 1994; 22: 205–211.

    Article  CAS  PubMed  Google Scholar 

  66. Orlikowski CE, Payne AJ, Moodley J, Rocke DA . Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth 1992; 69: 159–161.

    Article  CAS  PubMed  Google Scholar 

  67. Kinouchi K, Fujita T, Narahara C, Kitamura S . Platelet function in pregnant women receiving aspirin and dipyridamole. J Anesth 2000; 14: 115–118.

    Article  CAS  PubMed  Google Scholar 

  68. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER . Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113: 1564–1571.

    Article  PubMed  Google Scholar 

  69. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G . Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 234S–264S.

    Article  CAS  PubMed  Google Scholar 

  70. Thebault JJ, Kieffer G, Cariou R . Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost 1999; 25 (Suppl 2): 3–8.

    CAS  PubMed  Google Scholar 

  71. Thebault JJ, Kieffer G, Lowe GD, Nimmo WS, Cariou R . Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost 1999; 25 (Suppl 2): 9–14.

    CAS  PubMed  Google Scholar 

  72. Caplain H, Donat F, Gaud C, Necciari J . Pharmacokinetics of clopidogrel. Semin Thromb Hemost 1999; 25 (Suppl 2): 25–28.

    CAS  PubMed  Google Scholar 

  73. Lins R, Broekhuysen J, Necciari J, Deroubaix X . Pharmacokinetic profile of 14C-labeled clopidogrel. Semin Thromb Hemost 1999; 25 (Suppl 2): 29–33.

    CAS  PubMed  Google Scholar 

  74. Picard-Fraire C . Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function. Thromb Res Suppl 1983; 4: 119–128.

    Article  CAS  PubMed  Google Scholar 

  75. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Iovine C, Mancini M . Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985; 75: 328–338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Quinn MJ, Fitzgerald DJ . Ticlopidine and clopidogrel. Circulation 1999; 100: 1667–1672.

    Article  CAS  PubMed  Google Scholar 

  77. Kam PC, Nethery CM . The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 2003; 58: 28–35.

    Article  CAS  PubMed  Google Scholar 

  78. O'Reilly RA, Aggeler PM . Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev 1970; 22: 35–96.

    CAS  PubMed  Google Scholar 

  79. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G . Pharmacology and management of the vitamin K antagonists: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133: 160S–198S.

    Article  CAS  PubMed  Google Scholar 

  80. Marder VJ, Shulman NR . Clinical aspects of congenital factor VII deficiency. Am J Med 1964; 37: 182–194.

    Article  CAS  PubMed  Google Scholar 

  81. Brooks C, Rutherford JM, Gould J, Ramsay MM, James DK . Warfarin dosage in postpartum women: a case-control study. BJOG 2002; 109: 187–190.

    PubMed  Google Scholar 

  82. James AH . Thromboembolism in pregnancy: recurrence risks, prevention and management. Curr Opin Obstet Gynecol 2008; 20: 550–556.

    Article  PubMed  Google Scholar 

  83. James AH . Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 2009; 29: 326–331.

    Article  CAS  PubMed  Google Scholar 

  84. Levi M . Emergency reversal of antithrombotic treatment. Intern Emerg Med 2009; 4: 137–145.

    Article  PubMed  Google Scholar 

  85. Levy JH, Tanaka KA, Dietrich W . Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008; 109: 918–926.

    Article  CAS  PubMed  Google Scholar 

  86. Schulman S, Bijsterveld NR . Anticoagulants and their reversal. Transfus Med Rev 2007; 21: 37–48.

    Article  PubMed  Google Scholar 

  87. Ng HJ, Crowther MA . New anti-thrombotic agents: emphasis on hemorrhagic complications and their management. Semin Hematol 2006; 43: S77–S83.

    Article  CAS  PubMed  Google Scholar 

  88. Crowther MA, Berry LR, Monagle PT, Chan AK . Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin. Br J Haematol 2002; 116: 178–186.

    Article  CAS  PubMed  Google Scholar 

  89. Lauritzen B, Hedner U, Johansen PB, Tranholm M, Ezban M . Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats. J Thromb Haemost 2008; 6: 804–811.

    Article  CAS  PubMed  Google Scholar 

  90. Firozvi K, Deveras RA, Kessler CM . Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate. Am J Hematol 2006; 81: 582–589.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Stanford University School of Medicine, Stanford, CA, USA

    A J Butwick & B Carvalho

Authors
  1. A J Butwick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A J Butwick.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butwick, A., Carvalho, B. Anticoagulant and antithrombotic drugs in pregnancy: what are the anesthetic implications for labor and cesarean delivery?. J Perinatol 31, 73–84 (2011). https://doi.org/10.1038/jp.2010.64

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.64

Keywords

Search

Advanced search

Quick links